TRVI earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -53.88. Updated 2026-07-23.
Trevi Therapeutics (TRVI) Research Hub
Trevi Therapeutics (TRVI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 12.51 USD (-0.79%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -53.88, market cap 2.46B. This hub links to the full technical, earnings and options research available for TRVI.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 12.51 USD (-0.79%) |
| 52-week range | 11.705 USD – 20.15 USD |
| Trend regime | Range |
| 14-day RSI | 41 (Bearish) |
| Trailing P/E | -53.88 |
| Market cap | 2.46B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for TRVI
Covered Call on TRVI: how it works, illustrative setup around the real 12.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TRVI: how it works, illustrative setup around the real 12.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TRVI: how it works, illustrative setup around the real 12.51 USD price, max profit/loss, breakeven and when to use it. Educational.
TRVI technical analysis: range, last 12.51 USD, RSI 41, 52w range 11.705 USD–20.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TRVI in?
Trevi Therapeutics (TRVI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TRVI in an uptrend or downtrend?
As of 2026-10-26, TRVI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TRVI's trailing P/E ratio?
TRVI's trailing P/E is -53.88, with a market cap of 2.46B. See the earnings research page for full valuation detail.
When does TRVI next report earnings?
TRVI is next scheduled to report earnings on 2026-08-06.